Author

Yu-Ze Mao

Observed names: Yu-Ze MAO, Yuze Mao

Institutions: First Affiliated Hospital of Jiamusi University, Xi'an Jiaotong University

Observed institutions: First Affiliated Hospital of Jiamusi University, Xi'an Jiaotong University

ORCID: 0009-0005-3455-0646

Observed ORCID: 0009-0005-3455-0646

OpenAlex ID: A5101573033

Discovery of Potent PROTACs Targeting EGFR Mutants through the Optimization of Covalent EGFR Ligands

2022 · Hong-Yi Zhao, Hai-Peng Wang, et al. · Journal of Medicinal Chemistry · 95

Modification of osimertinib to discover new potent EGFRC797S-TK inhibitors

2023 · Xiao-Xiao Xi, Hong-Yi Zhao, et al. · European Journal of Medicinal Chemistry · 25

Design, synthesis and evaluation of new pyrimidine derivatives as EGFRC797S tyrosine kinase inhibitors

2023 · Yu-Ze Mao, Xiao-Xiao Xi, et al. · Bioorganic & Medicinal Chemistry Letters · 10

The anti-neoplastic activities of aloperine in HeLa cervical cancer cells are associated with inhibition of the IL-6-JAK1-STAT3 feedback loop

2021 · Yao-Dong CHEN, Fang-Yu CAI, et al. · Chinese Journal of Natural Medicines · 6

Identification Invasion-Related Long Non-Coding RNAs in Lung Adenocarcinoma and Analysis of Competitive Endogenous RNA Regulatory Networks

2023 · Yuze Mao, Fangyu Cai, et al. · International Journal of General Medicine · 2

Works count: 5

Citation count: 138

H-index: 4

I10-index: 3